e-Drug3D 121 |
PYRIMETHAMINE
|
cas 58-14-0 |
CLASS ANTIPARASITIC |
ROUTE (list) ORAL |
PK parameters Tmax 4 HOUR |
Target TARGET DIHYDROFOLATE REDUCTASE PDB Ligand code = CP6 (link to the list of PDB complexes) Download experimental 3D coordinates of CP6 with added hydrogens |
DrugCentral Bifunctional dihydrofolate reductase-thymidylate synthase UNIPROT P13922 |
Download SDF file | 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine Formula: Calculated chemical properties: MW 248.71 NB_atoms 17 XLogP 2.52 PSA 68.825 NB_HD 4 NB_HA 4 fsp3 0.17 Lipinski(0=no;1=yes) 1 |
FDA NDA 008578 (label) INN (PYRIMETHAMINE) DARAPRIM (TILDE SCIENCES) APPROVAL= AP YEAR= 1953 NEWMOLECULARENTITY NDA 018557 (label) INN (PYRIMETHAMINE ; SULFADOXINE) FANSIDAR (ROCHE) APPROVAL= AP YEAR= 1981 DISCONTINUED NDA 207127 (pdf not found) INN (PYRIMETHAMINE) PYRIMETHAMINE (SANALUZ) APPROVAL= AP YEAR= 2020 NDA 211271 (pdf not found) INN (PYRIMETHAMINE) PYRIMETHAMINE (ALVOGEN) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 215506 (pdf not found) INN (PYRIMETHAMINE) PYRIMETHAMINE (TEVA PHARMS) APPROVAL= AP YEAR= 2021 NDA 216983 (pdf not found) INN (PYRIMETHAMINE) PYRIMETHAMINE (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2022 |
Other links: |